Current applications and future developments of positron emission tomography in head and neck cancer;Progrès en imagerie des tumeurs de la sphère cervico-maxillofaciale: La tomographie par émission de positons (TEP-scan)

Cancer/Radiotherapie

Volumn 9, Issue 1, 2005, Pages 8-15

  Lonneux, M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Diagnosis; FDG; Head and neck tumors; Hypoxia; PET scan; Radiotherapy; Recurrence; Staging; Volume definition

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

CANCER DIAGNOSIS; CANCER RELAPSE; CANCER STAGING; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DISEASE COURSE; HEAD AND NECK CANCER; HUMAN; HYPOXIA; IMAGING SYSTEM; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RADIODIAGNOSIS; REVIEW; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 15944381928     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.01.002     Document Type: Short Survey

References (77)

1. S. Adams, R.P. Baum, T. Stuckensen, K. Bitter, and G. Hor Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer Eur. J. Nucl. Med. 25 1998 1255 1260
2. A.S. Allal, P. Dulguerov, M. Allaoua, C.A. Haenggeli, A. El-Ghazi el, and W. Lehmann Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J. Clin. Oncol. 20 2002 1398 1404
3. Y. Anzai, W.R. Carroll, D.J. Quint, C.R. Bradford, S. Minoshima, and G.T. Wolf Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses Radiology 200 1996 135 141
4. S.F. Barrington, and M.N. Maisey Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam J. Nucl. Med. 37 1996 1127 1129
5. H. Barthel, H. Wilson, D.R. Collingridge, G. Brown, S. Osman, and S.K. Luthra In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography Br. J. Cancer 90 2004 2232 2242
6. M. Benchaou, W. Lehmann, D.O. Slosman, M. Becker, R. Lemoine, and D. Rufenacht The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer Acta Otolaryngol. 116 1996 332 335
7. L. Bentzen, S. Keiding, M. Nordsmark, L. Falborg, S.B. Hansen, and J. Keller Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours Radiother. Oncol. 67 2003 339 344
8. J.W. Braams, J. Pruim, N.J. Freling, P.G. Nikkels, J.L. Roodenburg, and G. Boering Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI J. Nucl. Med. 36 1995 211 216
9. D.C. Cobben, B.F. Van der Laan, B. Maas, W. Vaalburg, A.J. Suurmeijer, and H.J. Hoekstra 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET J. Nucl. Med. 45 2004 226 231
10. C. Cohade, M. Osman, H.K. Pannu, and R.L. Wahl Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT J. Nucl. Med. 44 2003 170 176
11. J.F. Daisne, T. Duprez, B. Weynand, M. Lonneux, M. Hamoir, and H. Reychler Tumor Volume in Pharyngolaryngeal Squamous Cell Carcinoma: Comparison at CT, MR Imaging, and FDG PET and Validation with Surgical Specimen Radiology 2004
12. J.F. Daisne, M. Sibomana, A. Bol, G. Cosnard, M. Lonneux, and V. Gregoire Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency Radiother. Oncol. 69 2003 237 245
13. J.F. Daisne, M. Sibomana, A. Bol, T. Doumont, M. Lonneux, and V. Gregoire Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother. Oncol. 69 2003 247 250
14. T.A. Dalsaso, V.J. Lowe, F.R. Dunphy, D.S. Martin, J.H. Boyd, and B.C. Stack FDG-PET and CT in Evaluation of Chemotherapy in Advanced Head and Neck Cancer Clin. Positron Imaging 3 2000 1 5
15. J.R. De Boer, J. Pruim, F. Burlage, A. Krikke, A.T. Tiebosch, and F.W. Albers Therapy evaluation of laryngeal carcinomas by tyrosine-pet Head Neck 25 2003 634 644
16. J.R. De Boer, J. Pruim, B.F. Van der Laan, T.H. Que, A.T. Willemsen, and F.W. Albers L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate J. Nucl. Med. 44 2003 341 346
17. J.R. De Boer, B.F. Van der Laan, J. Pruim, T.H. Que, F. Burlage, and A. Krikke Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas Eur. J. Nucl. Med. Mol. Imaging 29 2002 1182 1187
18. F. De Braud, and M. Al-Sarraf Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck Semin. Oncol. 20 1993 273 278
19. E. Di Martino, B. Nowak, H.A. Hassan, R. Hausmann, G. Adam, and U. Buell Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings Arch. Otolaryngol. Head Neck Surg. 126 2000 1457 1461
20. S.M. Evans, A.V. Kachur, C.Y. Shiue, R. Hustinx, W.T. Jenkins, and G.G. Shive Non-invasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1 J. Nucl. Med. 41 2000 327 336
21. L.A. Farber, F. Benard, M. Machtay, R.J. Smith, R.S. Weber, and G.S. Weinstein Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography Laryngoscope 109 1999 970 975
22. G.B. Fogarty, L.J. Peters, J. Stewart, C. Scott, D. Rischin, and R.J. Hicks The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor Head Neck 25 2003 138 155
23. X. Geets, J.F. Daisne, V. Gregoire, M. Hamoir, and M. Lonneux Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT Radiother. Oncol. 71 2004 267 273
24. G.W. Goerres, D.T. Schmid, K.W. Gratz, G.K. Von Schulthess, and G.K. Eyrich Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity Oral Oncol. 39 2003 547 551
25. G.W. Goerres, G.K. Von Schulthess, and T.F. Hany Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment AJR Am. J. Roentgenol. 179 2002 1337 1343
26. K.M. Greven, J.W. Keyes Jr., D.W. Williams 3rd, W.F. McGuirt, and W.T. Joyce 3rd Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose Cancer 86 1999 114 118
27. K.M. Greven, D.W. Williams 3rd, W.F. McGuirt Sr., B.A. Harkness, R.B. D'Agostino Jr., and J.W. Keyes Jr. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck 23 2001 942 946
28. T. Gronroos, L. Bentzen, P. Marjamaki, R. Murata, M.R. Horsman, and S. Keiding Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma Eur. J. Nucl. Med. Mol. Imaging 31 2004 513 520
29. M.M. Hanasono, L.D. Kunda, G.M. Segall, G.H. Ku, and D.J. Terris Uses and limitations of FDG positron emission tomography in patients with head and neck cancer Laryngoscope 109 1999 880 885
30. A. Hannah, A.M. Scott, H. Tochon-Danguy, J.G. Chan, T. Akhurst, and S. Berlangieri Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer Ann. Surg. 236 2002 208 217
31. J. Johansen, A. Eigtved, C. Buchwald, S.A. Theilgaard, and H.S. Hansen Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study Laryngoscope 112 2002 2009 2014
32. M. Jungehulsing, K. Scheidhauer, M. Damm, U. Pietrzyk, H. Eckel, and H. Schicha 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation Otolaryngol. Head Neck Surg. 123 2000 294 301
33. C.H. Kao, J.F. Hsieh, S.C. Tsai, Y.J. Ho, R.F. Yen, and S.P. ChangLai Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma Ann Otol Rhinol Laryngol 109 2000 1130 1134
34. Y. Kitagawa, S. Nishizawa, K. Sano, T. Ogasawara, M. Nakamura, and N. Sadato Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma J. Nucl. Med. 44 2003 198 206
35. Y. Kitagawa, K. Sano, S. Nishizawa, M. Nakamura, T. Ogasawara, and N. Sadato FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer Eur. J. Nucl. Med. Mol. Imaging 30 2003 63 71
36. L. Kostakoglu, J.C. Wong, S.F. Barrington, B.F. Cronin, A.M. Dynes, and M.N. Maisey Speech-related visualization of laryngeal muscles with fluorine-18-FDG J. Nucl. Med. 37 1996 1771 1773
37. E. Kresnik, P. Mikosch, H.J. Gallowitsch, D. Kogler, S. Wiesser, and M. Heinisch Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods Eur. J. Nucl. Med. 28 2001 816 821
38. K. Kubota, J. Yokoyama, K. Yamaguchi, S. Ono, A. Qureshy, and M. Itoh FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT Eur. J. Nucl. Med. Mol. Imaging 31 2004 590 595
39. R. Kubota, S. Yamada, K. Kubota, K. Ishiwata, N. Tamahashi, and T. Ido Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J. Nucl. Med. 33 1992 1972 1980
40. M. Lapela, A. Eigtved, S. Jyrkkio, R. Grenman, T. Kurki, and P. Lindholm Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer Eur. J. Cancer 36 2000 858 867
41. M. Lapela, R. Grenman, T. Kurki, H. Joensuu, S. Leskinen, and P. Lindholm Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2- deoxy-D-glucose Radiology 197 1995 205 211
42. U. Lassen, G. Daugaard, A. Eigtved, K. Damgaard, and L. Friberg 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT) Eur. J. Cancer 35 1999 1076 1082
43. C. Laubenbacher, D. Saumweber, C. Wagner-Manslau, R.J. Kau, M. Herz, and N. Avril Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas J. Nucl. Med. 36 1995 1747 1757
44. K. Lehtio, O. Eskola, T. Viljanen, V. Oikonen, T. Gronroos, and L. Sillanmaki Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer Int. J. Radiat. Oncol. Biol. Phys. 59 2004 971 982
45. P. Lindholm, S. Leskinen-Kallio, H. Minn, J. Bergman, M. Haaparanta, and P. Lehikoinen Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer J. Nucl. Med. 34 1993 1711 1716
46. M. Lonneux, G. Lawson, C. Ide, R. Bausart, M. Remacle, and S. Pauwels Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient Laryngoscope 110 2000 1493 1497
47. V.J. Lowe, J.H. Boyd, F.R. Dunphy, H. Kim, T. Dunleavy, and B.T. Collins Surveillance for recurrent head and neck cancer using positron emission tomography J. Clin. Oncol. 18 2000 651 658
48. P. Mahy, M. De Bast, P.H. Leveque, J. Gillart, D. Labar, and J. Marchand Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3 Eur. J. Nucl. Med. Mol. Imaging 31 2004 1263 1272
49. S. Manolidis, P.J. Donald, P. Volk, and T.R. Pounds The use of positron emission tomography scanning in occult and recurrent head and neck cancer Acta Otolaryngol. Suppl. 534 1998 1 11
50. W.F. McGuirt, K.M. Greven, J.W. Keyes Jr., D.W. Williams 3rd, and N. Watson Laryngeal radionecrosis vs recurrent cancer: a clinical approach Ann Otol Rhinol Laryngol 107 1998 293 296
51. W.F. McGuirt, D.W. Williams 3rd, J.W. Keyes Jr., K.M. Greven, N.E. Watson Jr., and K.R. Geisinger A comparative diagnostic study of head and neck nodal metastases using positron emission tomography Laryngoscope 105 1995 373 375
52. H. Minn, A.C. Clavo, R. Grenman, and R.L. Wahl In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck J. Nucl. Med. 36 1995 252 258
53. H. Minn, M. Lapela, P.J. Klemi, R. Grenman, S. Leskinen, and P. Lindholm Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer J. Nucl. Med. 38 1997 1907 1911
54. L.L. Myers, M.K. Wax, H. Nabi, G.T. Simpson, and D. Lamonica Positron emission tomography in the evaluation of the N0 neck Laryngoscope 108 1998 232 236
55. J. Nuutinen, S. Jyrkkio, P. Lehikoinen, P. Lindholm, and H. Minn Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography Radiother. Oncol. 52 1999 225 232
56. A.A. Os, N.J. Fischbein, G.R. Caputo, M.J. Kaplan, D.C. Price, and M.I. Singer Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors Radiology 210 1999 177 181
57. P. Paulus, A. Sambon, D. Vivegnis, R. Hustinx, P. Moreau, and J. Collignon 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients Laryngoscope 108 1998 1578 1583
58. S. Rege, A.A. Safa, L. Chaiken, C. Hoh, G. Juillard, and H.R. Withers Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas Am. J. Clin. Oncol. 23 2000 164 169
59. G. Regelink, J. Brouwer, R. De Bree, J. Pruim, B.F. Van der Laan, and W. Vaalburg Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities Eur. J. Nucl. Med. Mol. Imaging 29 2002 1024 1030
60. J.W. Rogers, K.M. Greven, W.F. McGuirt, J.W. Keyes Jr., D.W. Williams 3rd, and N.E. Watson Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int. J. Radiat. Oncol. Biol. Phys. 58 2004 694 697
61. C. Scarfone, W.C. Lavely, A.J. Cmelak, D. Delbeke, W.H. Martin, and D. Billheimer Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging J. Nucl. Med. 45 2004 543 552
62. H. Schoder, H.W. Yeung, M. Gonen, D. Kraus, and S.M. Larson Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion Radiology 231 2004 65 72
63. D.L. Schwartz, J. Rajendran, B. Yueh, M. Coltrera, Y. Anzai, and K. Krohn Staging of head and neck squamous cell cancer with extended-field FDG-PET Arch. Otolaryngol. Head Neck Surg. 129 2003 1173 1178
64. M.B. Sigg, H. Steinert, K. Gratz, P. Hugenin, S. Stoeckli, and G.K. Eyrich Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities J. Oral Maxillofac. Surg. 61 2003 1022 1029
65. K. Spaepen, S. Stroobants, G. Verhoef, and L. Mortelmans Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients Eur. J. Nucl. Med. Mol. Imaging 30 Suppl 1 2003 S97 S105
66. S.J. Stoeckli, K. Mosna-Firlejczyk, and G.W. Goerres Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 30 2003 411 416
67. S.J. Stoeckli, H. Steinert, M. Pfaltz, and S. Schmid Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma Head Neck 24 2002 345 349
68. M.P. Stokkel, C.H. Terhaard, G.J. Hordijk, and P.P. Van Rijk The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography Oral Oncol. 35 1999 390 394
69. T. Stuckensen, A.F. Kovacs, S. Adams, and R.P. Baum Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI J. Craniomaxillofac. Surg. 28 2000 319 324
70. T.N. Teknos, E.L. Rosenthal, D. Lee, R. Taylor, and C.S. Marn Positron emission tomography in the evaluation of stage III and IV head and neck cancer Head Neck 23 2001 1056 1060
71. C.H. Terhaard, V. Bongers, P.P. Van Rijk, and G.J. Hordijk F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer Head Neck 23 2001 933 941
72. T. Torizuka, K.R. Zasadny, B. Recker, and R.L. Wahl Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies Radiology 207 1998 767 774
73. H. Vermeersch, D. Loose, H. Ham, A. Otte, and C. Van de Wiele Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers Eur. J. Nucl. Med. Mol. Imaging 30 2003 1689 1700
74. J.P. Vuillez Ḿtabolisme glucidique des cellules tumorales:: conśquences pour l'utilisation de radiopharmaceutiques analogues du glucose Ḿdecine Nucĺaire-Imagerie fonctionnelle et ḿtabolique 22 1998 9 29
75. R.J. Wong, D.T. Lin, H. Schoder, S.G. Patel, M. Gonen, and S. Wolden Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma J. Clin. Oncol. 20 2002 1208 4199
76. W.L. Wong, E.B. Chevretton, M. McGurk, K. Hussain, J. Davis, and R. Beaney A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma Clin. Otolaryngol. 22 1997 209 214
77. M. Yao, M.M. Graham, H.T. Hoffman, R.B. Smith, G.F. Funk, and S.M. Graham The role of postradiation therapy FDG PET in prediction of necessity for postradiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma Int. J. Radiat. Oncol. Biol. Phys. 59 2004 1001 1010